Magazine Article | January 9, 2018

Companies To Watch: Daré Bioscience

Source: Life Science Leader

By Wayne Koberstein, Executive Editor, Life Science Leader magazine
Follow Me On Twitter @WayneKoberstein

Bringing to commercialization women’s reproductive health products — starting with a novel contraceptive.

SNAPSHOT
Daré Bioscience is a public company focusing on women’s reproductive health and developing Ovaprene, a novel, vaginally inserted contraceptive ring about to enter clinical trials. Ovaprene is designed to prevent pregnancy by impeding sperm motility with slow-release of ascorbic acid and the iron compound ferrous gluconate from the ring’s permeable mesh. Ovaprene is the first clinical candidate of Daré, which aims to be a global player in developing products that fill the unmet, often overlooked reproductive health needs of women.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: